{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:45:09Z","timestamp":1774489509578,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA091846"],"award-info":[{"award-number":["P50CA091846"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006280","name":"Urology Care Foundation","doi-asserted-by":"publisher","award":["IRG 85-001-25"],"award-info":[{"award-number":["IRG 85-001-25"]}],"id":[{"id":"10.13039\/100006280","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.urolonc.2022.10.015","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T08:14:11Z","timestamp":1668672851000},"page":"108.e11-108.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8098-901X","authenticated-orcid":false,"given":"Patrick J.","family":"Hensley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Bree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niyati","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Contieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles C.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neema","family":"Navai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin P.","family":"Dinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3546-9928","authenticated-orcid":false,"given":"Ashish M.","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2022.10.015_bib0001","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0002","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2017.04.086","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO guideline","volume":"198","author":"Chang","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0003","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/JU.0000000000001633","article-title":"Contemporary outcomes of patients with non-muscle invasive bladder cancer treated with BCG therapy: implications for clinical trial design","volume":"205","author":"Matulay","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0004","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00345-010-0626-3","article-title":"Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study","volume":"29","author":"Porter","year":"2011","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0006","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0007","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1002\/cncr.30164","article-title":"Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008","volume":"122","author":"Donin","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0008","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.euo.2018.03.005","article-title":"Systematic review of comorbidity and competing-risks assessments for bladder cancer patients","volume":"1","author":"Williams","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0009","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12913-020-05533-7","article-title":"Development and evaluation of a bladder cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach","volume":"20","author":"Lee","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11934-018-0860-6","article-title":"Bladder cancer survivorship","volume":"19","author":"Bhanvadia","year":"2018","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0011","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1002\/cncr.30136","article-title":"Patient-centered support in the survivorship care transition: outcomes from the patient-owned survivorship care plan intervention","volume":"122","author":"Kvale","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0012","first-page":"465","article-title":"Second primary lung cancer in United States Cancer Survivors, 1992-2008","volume":"30","author":"Donin","year":"2019","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0013","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/10428190109057981","article-title":"Therapy related leukemias: susceptibility, prevention and treatment","volume":"41","author":"Leone","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0014","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.1990.03450080092038","article-title":"Poor survival of treatment-related acute nonlymphocytic leukemia","volume":"264","author":"Neugut","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00129804-200311000-00004","article-title":"Chemotherapy-induced secondary malignancies","volume":"26","author":"Vega-Stromberg","year":"2003","journal-title":"J Infus Nurs"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.28627","article-title":"Assessment of trends in second primary cancers in patients with metastatic melanoma from 2005 to 2016","volume":"3","author":"Deng","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0017","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0018","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ijc.32101","article-title":"Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States","volume":"145","author":"Adjei Boakye","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0019","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.21873\/anticanres.11548","article-title":"Second primary malignancy in bladder carcinoma - a population-based study","volume":"37","author":"Khanal","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0020","doi-asserted-by":"crossref","first-page":"848.e17","DOI":"10.1016\/j.urolonc.2020.05.018","article-title":"Long-term outcomes of incidental prostate cancer at radical cystectomy","volume":"38","author":"Packiam","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2022.10.015_bib0021","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.juro.2013.05.034","article-title":"Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens","volume":"190","author":"Bruins","year":"2013","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922003933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922003933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:25:49Z","timestamp":1761042349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143922003933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1078143922003933"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.10.015","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}